Evidence map›Paper›PMID 32928962›Full record

ArticleThe Journal of biological chemistry2020

Decrease of core 2

Sarah A Flowers, Kristina A Thomsson, Liaqat Ali, Shan Huang, Yolanda Mthembu, Suresh C Regmi, Jan Holgersson, Tannin A Schmidt, Ola Rolfson, Lena I Björkman and 6 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Lubricin's Mucin Domain Has Strong Polyproline Type II Helical Character.Computational and structural biotechnology journal · 2026
    Article
  3. Article
  4. Silver Oxide Promoted Synthesis of AlphaThe Journal of organic chemistry · 2025
    Article
  5. Recombinant manufacturing of multispecies biolubricants.bioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Recombinant mucin biotechnology and engineering.Advanced drug delivery reviews · 2023
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Sarah A FlowersDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Kristina A ThomssonDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Liaqat AliDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Shan HuangDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Yolanda MthembuDepartment of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Suresh C RegmiFaculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada.
Jan HolgerssonDepartment of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Tannin A SchmidtBiomedical Engineering Department, University of Connecticut Health Center, Farmington, Connecticut, USA.
Ola RolfsonDepartment of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Lena I BjörkmanDepartment of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Martina SundqvistDepartment of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Anna Karlsson-BengtssonDepartment of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Chalmers University of Technology, Gothenburg, Sweden.
Gregory D JayDepartment of Emergency Medicine, Warren Alpert Medical School and Division of Biomedical Engineering, School of Engineering, Brown University, Providence, Rhode Island, USA.
Thomas EislerDepartment of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden.
Roman KrawetzDepartment of Cell Biology and Anatomy, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, Alberta, Canada.
Niclas G KarlssonDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address: niclas.karlsson@medkem.gu.se.
University of Gothenburg · SEUniversity of Calgary · CABrown University · USChalmers University of Technology · SEKarolinska Institutet · SEUConn Health · US

Funding

Non-tribologic Bioactivity of LubricinR01AR067748 · NIAMS · RHODE ISLAND HOSPITAL · PI ELSAID, KHALED AHMED, JAY, GREGORY D. · 2016 to 2020
$2.2M
NIAMS NIH HHS R01 AR067748
6 · The paper itself

Abstract

The synovial fluid glycoprotein lubricin (also known as proteoglycan 4) is a mucin-type

Indexed as

AdultAgedAnimalsBlood ProteinsCHO CellsCricetulusFemaleGalectinsHumansMaleMiddle AgedOsteoarthritisProteoglycan 4ProteoglycansSynovial MembraneBlood ProteinsGalectinsLGALS3 protein, humanPRG4 protein, humanProteoglycan 4Proteoglycansbiolubricationgalectinglycobiologyglycomicslubricinmucinosteoarthritissialic acid

Identifiers

PMID32928962
PMCPMC7681006
OpenAlexW3087685284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.